Filgrastim biosimilar(Curateq Biologics)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameFilgrastim biosimilar(Curateq Biologics)
Drug Alias NameBP13(Curateq Biologics)BP-13(Curateq Biologics)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/02/12
Country/TerritoryAustraliaEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCuraTeQ Biologics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuraTeQ Biologics Pvt Ltd
Inactive CompaniesN/A
Active IndicationsFebrile NeutropeniaNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A